Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Leukemia ; 27(2): 305-14, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22751451

ABSTRACT

Constitutively activated FLT3 signaling is common in acute myeloid leukemia, and is currently under evaluation for targeted therapy, whereas little data is available in T-cell acute lymphoblastic leukemia (T-ALL). We analyzed 357 T-ALL cases for FLT3 mutations and transcript expression. FLT3 mutations (3% overall) and overexpression (FLT3 high expresser (FLT3(High))) were restricted to immature/TCRγδ T-ALLs. In vitro FLT3 inhibition induced apoptosis in only 30% of FLT3(High) T-ALLs and did not correlate with mutational status. In order to investigate the mechanisms of primary resistance to FLT3 inhibition, a broad quantitative screen for receptor kinome transcript deregulation was performed by Taqman Low Density Array. FLT3 deregulation was associated with overexpression of a network of receptor kinases (RKs), potentially responsible for redundancies and sporadic response to specific FLT3 inhibition. In keeping with this resistance to FLT3 inhibition could be reversed by dual inhibition of FLT3 and KIT with a synergistic effect. We conclude that immature T-ALL may benefit from multitargeted RK inhibition and that exploration of the receptor kinome defines a rational strategy for testing multitarget kinase inhibition in malignant diseases.


Subject(s)
Apoptosis/drug effects , Drug Resistance, Neoplasm/genetics , Mutation/genetics , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/enzymology , Protein Kinase Inhibitors/pharmacology , Receptor Protein-Tyrosine Kinases/antagonists & inhibitors , fms-Like Tyrosine Kinase 3/antagonists & inhibitors , Adolescent , Adult , Aged , Child , Child, Preschool , DNA, Neoplasm/genetics , Drug Synergism , Female , Flow Cytometry , Follow-Up Studies , Humans , Infant , Male , Middle Aged , Polymerase Chain Reaction , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/genetics , Prognosis , Receptor Protein-Tyrosine Kinases/genetics , Receptor Protein-Tyrosine Kinases/metabolism , Signal Transduction , Survival Rate , Tumor Cells, Cultured , Young Adult , fms-Like Tyrosine Kinase 3/genetics , fms-Like Tyrosine Kinase 3/metabolism
2.
Leukemia ; 19(8): 1338-44, 2005 Aug.
Article in English | MEDLINE | ID: mdl-15973457

ABSTRACT

The t(6;9)(p23;q34) is a recurrent chromosomal abnormality observed in 1% of acute myelogenous leukemia (AML), which generates a fusion transcript between DEK and CAN/NUP214 genes. We used a DEK-CAN real-time quantitative (RQ)-PCR strategy to analyze 79 retrospective and prospective samples from 12 patients. Five patients reached DEK-CAN negativity (sensitivity 10(-5)); all underwent early allogeneic hematopoietic stem cell transplantation (median 5.5 months from diagnosis) with some demonstrating molecular positivity at the time of allograft. All four cases in CCR with adequate follow-up (median 18.5 months, range 13--95) demonstrate persistent molecular negativity, whereas all seven patients with persistent DEK-CAN positivity died at a median of 12 months from diagnosis (range 7--27). We conclude that DEK-CAN molecular monitoring by RQ-PCR in t(6;9) malignancies is a useful tool for individual patient management and that molecular negativity is indispensable for survival, but should not be a prerequisite for allografting in this rare, poor prognosis, subset of AML.


Subject(s)
Leukemia, Myeloid/diagnosis , Molecular Diagnostic Techniques , Oncogene Proteins/analysis , Recombinant Fusion Proteins/analysis , Adolescent , Adult , Child , Child, Preschool , Female , Follow-Up Studies , Hematopoietic Stem Cell Transplantation , Humans , Leukemia, Myeloid/mortality , Leukemia, Myeloid/therapy , Male , Middle Aged , Oncogene Proteins/genetics , Oncogene Proteins, Fusion/analysis , Oncogene Proteins, Fusion/genetics , Polymerase Chain Reaction , Prognosis , Recombinant Fusion Proteins/genetics , Survival Rate
3.
Folia Histochem Cytobiol ; 39(4): 335-40, 2001.
Article in English | MEDLINE | ID: mdl-11766769

ABSTRACT

The aim of this study was to evaluate angiogenesis in tissue of the pancreatic ductal adenocarcinoma and to correlate it with histopathological data such as tumour differentiation, tumour size, lymph node metastasis and patients survival. Tumour samples obtained during surgery from 36 patients were immunostained for the presence of blood vessels with monoclonal antibody against the CD31 molecule. Evaluation of microvasculature was perfomed by counting the microvessel density (MVD) in selected areas under light microscope as well as by computer assisted image analysis (CAIA). In the latter, the following parameters were used for assessment of microvessels: mean number/field, mean area of the vessels, total area/field and total perimeter/field. MVD values obtained under optical microscope and with CAIA were highly correlated. All parameters characterising microvasculature in CAIA also revealed a significant correlation with the histological grading of tumours; generally the less differentiated tumours manifested more extensive vascular network. No significant relationship was found between the tumour size and any of the CAIA parameters. The area of vessels (both total and mean values) revealed a significant, inverse correlation with the incidence of lymph node metastases. The same type of correlation was also found between the mean vessel area and the postoperative survival period. The results show that CAIA of microvessels offers new parameters with some predictive value for the outcome of patients with pancreatic cancer.


Subject(s)
Carcinoma, Pancreatic Ductal/blood , Carcinoma, Pancreatic Ductal/pathology , Image Processing, Computer-Assisted/methods , Pancreatic Neoplasms/blood , Pancreatic Neoplasms/pathology , Carcinoma, Pancreatic Ductal/surgery , Female , Humans , Lymphatic Metastasis , Male , Microcirculation/pathology , Neovascularization, Pathologic , Pancreatic Neoplasms/surgery , Prognosis , Treatment Outcome
4.
Przegl Lek ; 56 Suppl 1: 17-21, 1999.
Article in Polish | MEDLINE | ID: mdl-10494177

ABSTRACT

The article presents the available data considering the functioning of the basic level of hematopoiesis: stem cell population. The modern concepts refer to the achievements in the field of stem cell research with particular focus on the milestones in the experimental haematology. The analysis of the structure and function of the CD 34 molecule--the main marker of the hematopoietic stem cell population--underline the close relationship between molecular biology and clinical practice. Presentation of the advantages and disadvantages of peripheral blood stem cell transplantation--opens the way to the detailed clinical discussions and presentation of our own experience gained during last year.


Subject(s)
Antigens, CD34/metabolism , Biomarkers/analysis , Hematopoiesis/physiology , Animals , Hematopoietic Stem Cell Transplantation , Humans
5.
Pneumonol Alergol Pol ; 66(3-4): 221-5, 1998.
Article in Polish | MEDLINE | ID: mdl-9857668

ABSTRACT

20 years old man with history of acute allergic alveolitis 7 years ago, was admitted to hospital because of dyspnea, fever and cough after massive exposition to organic dust. Corticosteroids were introduced. During 3-weeks treatment respiratory failure progressed. Chest x-ray showed massive bilateral nodular opacities. Antibiotic therapy was not effective. The autopsy revealed invasive pulmonary aspergillosis. Presence of precipitins to aspergillus fumigatus was confirmed postmortem. Diagnostic difficulties are discussed.


Subject(s)
Aspergillosis, Allergic Bronchopulmonary/diagnosis , Aspergillus fumigatus/isolation & purification , Adult , Aspergillosis, Allergic Bronchopulmonary/drug therapy , Fatal Outcome , Humans , Male
6.
J Cardiovasc Risk ; 5(4): 239-47, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9919472

ABSTRACT

Elevated plasma homocysteine is an independent risk factor for atherosclerosis and thrombosis. The exact mechanism by which homocysteine exerts its atherothrombotic action is still unclear. Accumulating evidence suggests that hyperhomocysteinaemia leads to endothelial injury and dysfunction, mediated by free radicals generated during the oxidation of homocysteine. Homocysteine also stimulates the proliferation of vascular smooth-muscle cells and inhibits the growth of vascular endothelial cells. Elevated homocysteine levels may also promote thrombosis by increased generation of thrombin. Other possible mechanisms for homocysteine-mediated atherogenesis include: the altered methylation of DNA and altered regulatory proteins associated with cell membrane, decreased bioavailability of nitric oxide, increased elastolysis and collagen accumulation, overstimulation of N-methyl-D-aspartate receptors and excessive adhesion of monocytes and neutrophils to endothelium. Understanding the mechanisms in vivo by which hyperhomocysteinaemia is associated with vascular disease may provide new approaches to prevention and treatment of atherothrombosis.


Subject(s)
Arteriosclerosis/etiology , Homocysteine/blood , Hyperhomocysteinemia/complications , Thrombosis/etiology , Arteriosclerosis/epidemiology , Endothelium, Vascular/pathology , Hemostasis , Humans , Hyperhomocysteinemia/epidemiology , Lipid Peroxidation , Muscle, Smooth, Vascular/pathology , Risk Factors , Thrombosis/epidemiology
7.
Anticancer Drugs ; 8(9): 859-68, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9402313

ABSTRACT

Pulmonary side effects are increasingly observed as dose-limiting toxicity (DLT) of cancer treatment. The available preclinical models have a limited predictive value for lung toxicity in humans. We have attempted to elucidate potential mechanisms involved in these reactions, by studying the effects on cells, possibly involved in these reactions after in vitro exposure to drugs with known lung toxic effects. We have investigated the effects of bleomycin (BLM), mitomycin C (MMC), KW-2149 and its two known metabolites, M16 and M18, on oxygen radical production by granulocytes, on cytokine production: interleukin (IL)-6, transforming growth factor (TGF)-beta, tumor necrosis factor (TNF)-alpha by a human macrophage cell line (THP-1), by human endothelial cells (HVEC and HMEC) and a human colorectal cancer cell line (DLD-1), and on the cytotoxicity on endothelial cells in both confluent and non-confluent culture. The generation of oxygen radicals by normal and pre-stimulated granulocytes was not increased after preincubation with any of the drugs, at the concentrations tested. None of the cytokines (IL-6, TNF-alpha or TGF-beta) was found significantly increased in culture medium after exposure to any of the mitomycins. This was in contrast with the effect of BLM incubation, causing a rise in TGF-beta concentration. Both types of endothelial cells showed a dose-dependent, exposure duration-dependent, proliferation inhibition for all agents tested. This inhibitory effect was clearly proliferation dependent as shown by the increased inhibition in semi-confluent as opposed to confluent endothelial cell cultures. Both mitomycins tested were more cytotoxic than BLM to both confluent and proliferating endothelial cells.


Subject(s)
Antibiotics, Antineoplastic/toxicity , Bleomycin/toxicity , Mitomycins/toxicity , Cell Division/drug effects , Cell Survival/drug effects , Cells, Cultured , Cytokines/biosynthesis , Endothelium/cytology , Endothelium/drug effects , Endothelium/metabolism , Granulocytes/drug effects , Granulocytes/metabolism , Humans , Macrophages/drug effects , Macrophages/metabolism , Superoxides/metabolism , Tumor Cells, Cultured
9.
Breast Cancer Res Treat ; 42(2): 165-72, 1997 Jan.
Article in English | MEDLINE | ID: mdl-9138605

ABSTRACT

In this study on the determination of intratumoral microvessel density (MVD) in breast cancer, we have investigated the influence of the observer experience and the microscopic field size. We have used the sample set reported on earlier in the J Natl Cancer Inst 87: 1797-1798, 1995. This case-control study has shown a positive association of high MVD and unfavorable outcome when comparing node-negative pT1-2 breast carcinoma (NNBC) patients with a disease-free period of over ten years with those with an early distant relapse. Tumor sections of both outcome groups (favorable: n = 19; unfavorable: n = 19) were immunostained for factor VIII related-antigen (FVIII r-Ag). Microvessels were counted in the areas of most intense vascularization ('hot spots'), both at magnification x 200 (field size of 0.61 square mm) and x 400 (field size of 0.15 square mm), by one inexperienced and three experienced observers. Microphotographs of individual vascular hot spots were analyzed using overlays resembling the two field sizes. The main results obtained are: i) a confirmation of the prognostic value of microvessel density in the case-control sample set (n = 38) was established by all experienced but not by the unexperienced investigator; ii) both at x 200 and x 400 magnification, angiogenesis quantification in vascular hot spots contained prognostic information. The results of this study indicate that the selection of vascular hot spots in tumor sections immunostained for an antigen expressed on endothelial cells is more prone to inter-observer variability and more dependent on training than the counting of the microvessels within predefined hot spots itself. The microscopic magnification and resulting field size do not influence the prognostic significance of MVD in NNBC. This information validates the development of more objective methods of measuring the amount of angiogenesis within malignant tissue. This will allow more accurate implementation of the angiogenesis parameter in multiparametric and prospective prognostic factor studies in NNBC.


Subject(s)
Adenocarcinoma/blood supply , Adenocarcinoma/pathology , Breast Neoplasms/blood supply , Breast Neoplasms/pathology , Neovascularization, Pathologic , Adenocarcinoma/therapy , Breast Neoplasms/therapy , Case-Control Studies , Disease-Free Survival , Humans , Lymphatic Metastasis , Microscopy/methods , Neoplasm Staging , Observer Variation , Treatment Outcome
10.
Pol Arch Med Wewn ; 96(4): 354-8, 1996 Oct.
Article in Polish | MEDLINE | ID: mdl-9082346

ABSTRACT

We describe a large family with hyperhomocysteinemia, the first to be reported in Poland. The proband's coronary complaints appeared at the age of 20, and by the age of 50 he had suffered extensive myocardial infarction. Examination of 17 persons from 4 generations revealed hyperhomocysteinemia in 2 daughters of the proband, while more discrete abnormalities were detected during methionine loading test in two other persons. Levels of cystathionone beta-syntetase and methyleno-FH4 reductase were normal in skin fibroblast culture. Treatment with folic acid and vitamin B12 led to 5-fold depression of plasma homocysteine in the proband, and complete normalization in the other treated member of the family.


Subject(s)
Arteriosclerosis/genetics , Homocysteine/blood , Myocardial Infarction/etiology , Adult , Aged , Arteriosclerosis/blood , Child , Child, Preschool , Female , Folic Acid/therapeutic use , Humans , Male , Middle Aged , Vitamin B 12/therapeutic use
13.
Pol Tyg Lek ; 48(5-6): 116-9, 1993.
Article in Polish | MEDLINE | ID: mdl-8361905

ABSTRACT

Fibrinolytic activity and tissue plasminogen activator (t-PA) level were measured in 33 healthy individuals prior to and after fibrinolytic system stimulation (i.e. a ten-minute venous stasis). Fibrinolytic activity was measured with the aid of euglobin lysis time, and lysis test on the fibrin plates (in own modification). Tissue plasminogen activator concentration was assayed spectrophotometrically with the COA-SET t-PA (Kabi Vitrum). No fibrinolytic activity of plasma specimens taken before the venous stasis was noted during fibrin lysis plate test whereas it was seen in 13 subjects after the venous stasis. Fibrinolytic activity of the plasma euglobins, measured as a surface on fibrin plates, increased significantly after the venous stasis in both sexes (by 35.5 mm2 on the average, i.e. by 51%). It was more marked in men than in women both prior to and after venous stasis (by 10.9% and 19.0%, respectively). A time of plasma euglobin lysis was shorter after venous stasis (by 110 minutes, on the average). There was no significant difference between the sexes. Tissue plasminogen activator concentration increased by 5.8 times (from 1.7 IU/ml to 9.9 IU/ml) after the stasis. Correlation between t-PA concentrations and fibrinolytic activity, measured on the fibrin plates, was highly positive. No such a correlation existed between t-PA concentrations and the time of euglobin lysis. The obtained results indicate variety of assessments of fibrinolytic system activity.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Fibrinolysis/physiology , Tissue Plasminogen Activator/blood , Veins/physiology , Adult , Constriction, Pathologic , Female , Humans , Male , Reference Values
SELECTION OF CITATIONS
SEARCH DETAIL
...